[1]
“Successful Treatment with Imipenem/Cilastatin/Relebactam of a Polymicrobial Bacteremia due to Meropenem/Vaborbactam-Resistant KPC-Producing Klebsiella pneumoniae and Enterococcus faecalis”, Mediterr J Hematol Infect Dis, vol. 18, no. 1, p. e2026037, Apr. 2026, doi: 10.4084/MJHID.2026.037.